Liboro R, Schwartz A B, Conroy J, Conroy J, Brezin J, Vanderlinde R E, Krevolin L, Brodsky I
Department of Medicine, Hahneman University, Philadelphia, PA 19102.
ASAIO Trans. 1990 Apr-Jun;36(2):86-9. doi: 10.1097/00002480-199004000-00008.
Heparin-free hemodialysis allows demonstration of the intradialytic coagulation status not previously possible during standard heparin anticoagulant hemodialysis protocols in patients with end-stage renal disease. No evidence for consumptive coagulopathy was noted in the absence of heparin during hemodialysis with cuprophane hollow fiber dialyzers. Fibrinogen levels, euglobulin lysis time, and platelet counts remained stable throughout 3 hours of heparin-free hemodialysis. Serial thrombin times and platelet aggregation improved during heparin-free hemodialysis. Hemodialyzer volumes and the ultrafiltration coefficient decreased only minimally. The alternate pathway of complement activation associated with hemodialysis blood-membrane interaction is not prevented by heparin-free hemodialysis.
无肝素血液透析能够展现终末期肾病患者在标准肝素抗凝血液透析方案中之前无法实现的透析中凝血状态。在用铜仿空心纤维透析器进行无肝素血液透析时,未发现消耗性凝血病的证据。在3小时的无肝素血液透析过程中,纤维蛋白原水平、优球蛋白溶解时间和血小板计数保持稳定。无肝素血液透析期间,连续凝血酶时间和血小板聚集情况有所改善。血液透析器容积和超滤系数仅略有下降。无肝素血液透析并不能防止与血液透析血膜相互作用相关的补体激活替代途径。